Studies strongly suggest that loss of PGR or P4 signaling pathways [43] and activation of the PI3K/AKT/mTOR pathway [44,45] lead to P4 resistance in various uterine diseases, including CAH and EEC. The gene discussed is AKT1; the disease is congenital adrenal hyperplasia.